Abstract. Serial changes in hepatitis A virus (HAV) and B virus (HBV) markers were determined from 1970 to 1996 in healthy Japanese residents of a rural area of Okinawa, Japan. All 190 serum samples taken in 1970, 791 in 1980, 708 in 1988, and 523 in 1996 from residents 0 to more than 60 years of age were tested for antibody to HAV (anti-HAV), antibody to hepatitis B core antigen (anti-HBc), and hepatitis B surface antigen (HBsAg). The ageadjusted prevalences of anti-HAV and anti-HBc decreased significantly from 83. 9% and 74.9%, respectively, in 1970 to 39.7% and 36.6%, respectively, in 1996. In residents Յ 29 years of age, the prevalences of anti-HAV and antiHBc decreased significantly from 65.3% and 83.8%, respectively, in 1970 to 0.7% and 8.2%, respectively, in 1996. The age-adjusted HBsAg prevalence decreased significantly from 8.2% in 1980 to 4.1% in 1988. These results indicate that exposure to HAV and HBV infections among Okinawa residents less than 29 years of age is decreasing, probably because of improvements in socioeconomic conditions since 1970. Infection with HBV may be eliminated there in the near future.
Infections with HAV and HBV have been extensively studied in various parts of the world, but long-term demographic data for all age groups have rarely been documented. Our previous reports confirmed that Okinawa, Japan was highly endemic for HAV and HBV infections. 10, 11 We also reported remarkable decreases in the prevalences of these viral infections in children and young adults in Okinawa from 1970 to 1988. 12 Determining changes in the prevalences of HAV and HBV infections with time is necessary if infection trends are to be predicted. We studied changes in the frequency of HAV and HBV infections over the 26-year period from 1970 to 1996 in Okinawa, Japan, an area previously endemic for these viral infections.
MATERIALS AND METHODS
This survey was done on Iriomote Island, a rural area of Okinawa, Japan, located in the subtropical zone about 1,000 km south of the main islands of Japan, which lie in the temperate zone. The Yaeyama District, with nine inhabited islands, is situated in the southwestern part of Okinawa, close to Taiwan. Iriomote Island is in the Yaeyama District and is a rural, farming area with a surface area of 289.27 km. 2 In 1996, the population of the western part of the island was 1,151 ( Figure 1 ).
We have surveyed inhabitants of the Yaeyama District of Okinawa since 1968 for HAV and HBV markers. The results of surveys carried out on Iriomote Island in 1970, 1980, and 1988 have been reported. [10] [11] [12] In 1996, we studied antibody to HAV (anti-HAV), hepatitis B surface antigen (HBsAg), and antibody to hepatitis B core antigen (anti-HBc) in serum samples collected from healthy inhabitants of all age groups living in the western part of Iriomote Island. We provided free health examinations and announced them by distributing written notices to all households. Serum samples were taken from 523 (45.4%) of the resident population who came to be examined. Approximately the same numbers of serum samples were obtained from men and women, with comparable numbers from each age group.
Informed written consent to participate in the study was obtained from each resident or their legal guardian, and the protocol of the study was reviewed and approved by the Ethic Committee of Kyushu University Hospital.
The 1996 results were compared with those of 1970, 1980, and 1988. We reported that serum samples were taken from 190 residents in 1970 (12.6% of the then resident population), 791 in 1980 (80.0% of the population), and 708 in 1988 (63.4% of the population). [10] [11] [12] We used the following methodology to test for HAV and HBV markers in all years.
We were able to follow 28 HBsAg-positive carriers from 1980 to 1996 and tested them for HBsAg subtype, hepatitis B e antigen (HBeAg), antibody to HBeAg (anti-HBe) status, and clearance of HBsAg (15 males and 13 females; the last observed age range was 14-84 years, mean Ϯ SD age ϭ 51.8 Ϯ 18.1 years).
Anti-HAV and anti-HBc were tested for by commercially available radioimmunoassays (HAVAB and CORAB; Abbott Laboratories, North Chicago, IL). Hepatitis B surface antigen was tested for by a reverse passive hemagglutination assay (MyCell; Institute of Immunology Co., Tokyo, Japan). The HBsAg-positive samples were tested for HBeAg and anti-HBe by a radioimmunoassay (HBeAg RIA; Abbott Laboratories). The HBsAg subtypes were determined by an ELI-SA using monoclonal antibodies (HBsAg subtype EIA; In- The chi-square test, the unpaired t-test, Fisher's exact method, and the Mantel-Haenszel test with a Bonfferoni correction were used for statistical analysis. P values Ͻ 0.05 were considered statistically significant.
RESULTS
Prevalence of anti-HAV. As shown in Table 1 , the ageadjusted prevalence of anti-HAV decreased significantly over the study period: 83.9% in 1970, 69.9% in 1980, 52.3% in 1988, and 39.7% in 1996 (P Ͻ 0.0001, by Mantel-Haenszel test with a Bonfferoni correction). Table 1 also shows changes in the age-specific prevalence for anti-HAV over the 26-year study period. In 1970, 99 (99.0%) of 100 adults were anti-HAV positive. The high anti-HAV prevalence in all age groups has shifted so that the highest prevalence is in the older age groups in 1996, suggesting an age-cohort effect.
The prevalence of anti-HAV in residents Յ 29 years of age in each testing period was compared. The prevalence decreased remarkably from 65.3% in 1970 to 0.7% in 1996. Significant differences in anti-HAV prevalence in those Յ 29 years of age were noted in each period (65.3% in 1970 versus 24.4% in 1980, 24.4% in 1980 versus 5.4% in 1988; both P Ͻ 0.0001 and 5.4% in 1988 versus 0.7% in 1996; P ϭ 0.0292, by chi-square test).
Prevalences of anti-HBc and HBsAg. The data in Table  2 indicate that the age-adjusted anti-HBc prevalence decreased through the period tested: 74.9% in 1970, 63.0% in 1980, 47.1% in 1988, and 36.6% in 1996 (P Ͻ 0.05, by Mantel-Haenszel test with a Bonfferoni correction). There were significant decreases between 1980 and 1988, and 1988 and 1996. In 1970, high anti-HBc prevalence was found in all age groups, especially in those Յ 39 years of age. The high anti-HBc prevalence in all age groups has shifted so that the high prevalence found in the age groups Ͻ 30-39 years of age in 1970 can now be seen in those Ͼ 50 years of age from 1980 to 1996, suggesting an age-cohort effect, as was found with anti-HAV prevalence.
A remarkable decrease in the anti-HBc prevalence was noted in those Յ 29 years of age as time passed. A comparison of the anti-HBc prevalence in those Յ 29 years of age was done in each testing period. The anti-HBc prevalence in residents Յ 29 years of age decreased from 83.8% in 1970 to 8.2% in 1996. Statistically significant differences were found between 1970 and 1980 and between 1980 and 1988 (P Ͻ 0.0001, by chi-square test).
The data in Table 3 show that the age-adjusted HBsAg prevalence gradually decreased from 12.4% in 1970 to 8.2% in 1980, and from 8.2% in 1980 to 4.1% in 1988; however, the prevalence did not change from 1988 (4.1%) to 1996 (4.2%). The decrease was significant only from 1980 to 1988 (P Ͻ 0.0001, by Mantel-Haenszel test with a Bonfferoni correction). Changes in age specific HBsAg prevalence over the past 26 years were also determined. Although the 0-9-(31.8 %) and 10-19-year-old age groups (21.4%) had high prevalences of HBsAg in 1970, the prevalences significantly decreased in 1996 to 0.0 % in the 0-9-year-old group and 2.1% (Table 4) . Hepatitis B surface antigen was cleared from the sera of eight (28.6%) of the 28 HBV carriers. The annual HBsAg clearance rate in HBV carriers was 1.8% in our study. Seroconversion from HBeAg to anti-HBe was found in all who cleared HBsAg by the start of the follow-up year, suggesting that HBsAg clearance occurred subsequent to HBeAg clearance. Although the HBsAg clearance rate in men (6 of 15, 40.0%) was higher than that in women (2 of 13, 15.4%) and that in carriers with subtype adr (3 of 10, 30.0%) was higher than that in carriers with subtype adw (4 of 15, 26.7%), there was no statistical significance by gender or HBsAg subtype (P ϭ 0.2213 and P ϭ 1.0, respectively, by Fisher's exact test). No statistically significant difference was found in clearance by age (mean age ϭ 54.1 years in the HBsAg clearance group versus 49.2 years in the HBsAg persistently positive group: P ϭ 0.6721, by unpaired t-test).
DISCUSSION
This study is a large-scale follow-up of HAV and HBV infections in a rural area of Okinawa, Japan. These two viruses are distinct in their natural history, epidemiologic patterns, and mechanisms of transmission. However, our study showed similar changes in the prevalences of anti-HAV and anti-HBc in residents of Iriomote Island, Okinawa. Szmuness and others 13 reported that there was a close correlation between the prevalences of anti-HAV and anti-HBc in the United States, Switzerland, Taiwan, and Senegal. In the present study, the tested number of serum samples and their proportion relative to the then resident population were different in each year; thus, the conclusions that can be drawn from such samples may have limited validity. We discuss here the relationship between these viral infections and decreases in their prevalence.
It is known that differences in anti-HAV prevalence between countries are probably related to differences in environmental and socioeconomic conditions. We reported the prevalence of anti-HAV in Okinawa to be significantly higher than in Kyushu, Japan. 10 Although the results from 1970 in this study showed a high prevalence of anti-HAV in all age groups, the prevalence has decreased remarkably, especially among people Յ 29 years of age. We also reported that we expected HAV infection to diminish because of improving sanitary conditions. 14 The historic hygienic and sanitary conditions in Okinawa no doubt facilitated the fecaloral spread of HAV infection, particularly among children. Sanitary conditions have improved tremendously on Iriomote Island over the last 26 years. For example, since the 1980s, most wooden huts have been replaced by reinforced concrete houses with flush toilets and a proper sewage disposal system, water supplies were improved by the addition of a piped system of chlorinated and filtered water, and medical facilities have been developed and improved. These changes all aided in minimizing the exposure of young people to HAV infection.
While the modes of HBV transmission are similar throughout the region, there is considerable variation in the importance of perinatal and household transmission, transmission by inoculation or blood transfusion, and secretions and sexual intercourse from country to country. 15, 16 Although most infections in low prevalence groups have been shown to be acquired in early adult life through experimentation with intravenous drugs and unprotected sexual intercourse, in hyperendemic areas the transmission is in childhood and probably horizontally through kissing, shared utensils such as toothbrushes and razors, and injections [17] [18] [19] either by the child's mother or some other people in the extended household. Our previous studies reported that the prevalence of HBV markers was significantly higher in Okinawa than in Kyushu, Japan. 11, 16 We also reported that there were many cases of apparent sibling-to-sibling transmission of HBV infection in the Yaeyama District, including Iriomote Island in the 1960s, 16 and that HBV transmission occurred among children in nursery schools. 20 We determined that this was because of transmission of body fluids among the children in the study district. Horizontal rather than neonatal materialinfant transmission of HBV was also reported to be the mode of spread of this infection, as it was in Africa in the 1980s. 21, 22 Hepatitis B virus has been transmitted to primates by inoculation with the saliva of HBV carriers. 23 Person-toperson transmission and transmission through vehicles contaminated with oral secretions from toothbrushes, baby bottles, toys, and chewing gum have been reported. 24, 25 We began educating the residents of this area in personal hygiene, especially in how to avoid contact with such the saliva and vehicles. Over the period from 1970 to 1996 studied in our report, HBV infection decreased as significantly as HAV infection. We are unable to address intravenous drug or condom use in the present study because we did not investigate them among these adult subjects. However, HBV infection, especially in the younger age groups, probably decreased with improvements in sanitary conditions and better hygienic education, resulting in reduced sharing of toothbrushes and earlier treatment of abrasions and cuts before contact could be made with lesions on other people.
The improvement in sanitary conditions is one of reasons that the decreases in HAV and HBV infections coincided on Iriomote Island. Maternal transmission has become relatively prominent as the mode of HBV transmission with the decrease in horizontal transmission. A changing pattern of intrafamilial HBV transmission was found compared with that of our earlier report on Okinawa. 26 Similar results showing a decrease of HBV infection among children were found in another survey of children attending nursery schools in Ishigaki City, the center of the Yaeyama District. 27 Since 1983, a combined administration of hepatitis B immunoglobulin and hepatitis B vaccine has become available for immunization. 28 Our study found a statistically significant difference in HBsAg prevalence in the comparison between 1980 and 1988. In January 1986, a nationwide program was begun in Japan to protect babies born to HBeAg-positive mothers by giving them combined passive and active immunization with single-use disposable syringes and needles. This program was extended to HBeAg-negative mothers who were HBsAg positive. Moreover, there had been changes in obstetrical practices from home delivery by relatives to hospital delivery in this area. Consequently, babies born to HBV carrier mothers began to receive proper immunization. Our finding of decreases in maternal transmission could the result of these immunization programs.
Decreases of carrier rates among young women of childbearing age may lead to elimination of maternal transmission of HBV infection. Some researchers have shown that chronic HBV infection was associated with a significantly increased risk of chronic liver disease. 29, 30 Beasley and others 29 showed that HBsAg carriers had more than 200 times the risk of developing primary liver cancer than did HBsAg-negative controls. The considerable reduction in the carrier rates among the young people we tested may significantly reduce the potential for HBV-induced liver disease.
The disappearance of HBsAg usually indicates clearance of HBV particles and coincides with the cessation of hepatocyte injury. 31, 32 The annual HBsAg clearance rate in HBV carriers has been reported to be 0.4-1.7%. [33] [34] [35] [36] [37] Compared with these reports, our study shows a higher clearance rate. We reported that the rate of seroconversion from HBeAg to anti-HBe was higher in HBsAg subtype adw than in HBsAg subtype adr in the Yaeyama district of Okinawa. 38 However, the present study shows no statistically significant difference in clearance by gender or HBsAg subtype. Interestingly, Hsu and others 36 found that carrier children born to noncarrier mothers cleared HBsAg much more frequently than did those born to carrier mothers, which means that carriers infected by horizontal transmission might have a higher clearance rate. We previously reported many cases of horizontal transmission in the district studied. 16 Although further studies involving a large number of chronic HBV carriers need to be done, the higher HBsAg clearance rate in this area might be related to the many cases caused by horizontal transmission.
Infections with HAV and HBV have decreased remarkably within the 26 years from 1970 to 1996 in one small area of Okinawa. These decreases seem to be the result of decreases in newly infected young people Յ 29 years of age. Although young people without anti-HAV remain highly susceptible to HAV, elimination of HBV from the area studied will be achieved in the near future.
